Clinical Trials Directory

Trials / Completed

CompletedNCT01471743

GI Surgery Pre-Operative Nutrition

The Effect of Pre-Operative Immunonutrition With "Impact Advanced Recovery (R)" on Patients Undergoing Major GI Cancer Surgery

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
108 (actual)
Sponsor
James A. Haley Veterans Administration Hospital · Federal
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Surgical patients are high risk for post operative infections. These post operative infections contribute to increased length of hospital stay, hospital costs and delay overall recovery time thus decreasing the quality of life. Studies have reported post operative complications ranging from 37% to 74%.1 The most costly complications include infectious complications after major Gastrointestinal (GI) surgery including wound infections, abdominal abscess, pneumonia, sepsis and anastomic leaks.2 Several studies have been conducted that show a significant reduction in infectious complications and average length of stay when treated with immunonutrition supplements.2-3 A review of similarly designed studies in a different patient population indicate that post-operative infections can be reduced by an average of 71% with immunonutrition. This study seeks to investigate the effect of Impact Advanced Recovery ® in improving surgical outcomes in patients receiving major gastrointestinal surgeries compared to a standard supplement at James A. Haley Veterans' Hospital. Providing Impact Advanced Recovery ® may decrease post-operative infectious complications, length of stay, and recovery time. Hypothesis 1. In patients receiving elective gastrointestinal surgery (esophageal, gastric, pancreatic or colon resections) there will be a significant decrease of at least 60% in post-operative infections as listed below for patients who consume 15 servings of Impact Advanced Recovery® pre-operatively compared to patients who consume 15 servings of a standard supplement. Complications to be considered: anastomatic leak, post-op wound development, post-op abdominal abscess, sepsis, pneumonia, post-op ileus, intestinal fistula, obstruction, urinary tract infections, peritonitis or bowel necrosis. 2. In patients receiving elective gastrointestinal surgery (esophageal, gastric, pancreatic or colon resections) there will be a significant decrease in hospital and NPO days for patients who consume 15 servings of Impact Advanced Recovery ® pre-operatively.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTImpact Advance Recovery (R)
DIETARY_SUPPLEMENTEnsure Plus (R)

Timeline

Start date
2011-11-01
Primary completion
2016-02-01
Completion
2016-02-01
First posted
2011-11-16
Last updated
2016-02-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01471743. Inclusion in this directory is not an endorsement.